Software, precision devices drive Australia’s diagnostic imaging growth

Australia held 4% of the APAC diagnostic imaging market in 2025.

Australia’s diagnostic imaging market is set to grow at around 5% CAGR from 2026 to 2036, driven by the adoption of software-driven and precision medical devices, according to GlobalData.

In 2025, Australia made up roughly 4% of the Asia-Pacific diagnostic imaging market, benefiting from steady technology uptake and ongoing investment in advanced devices.

“In the recent years, Australia’s diagnostic imaging sector has demonstrated steady progress in software-driven imaging technologies, supported by sustained funding and research activity,” said Shagufta Hasan, medical devices analyst at GlobalData. “Such developments reflect a growing emphasis on advancing and scaling the existing technologies to enhance clinical utility and support evolving healthcare needs.”

In January 2026, Australia-based 4DMedical raised over $100m to commercialise its CT:VQ device and expand adoption, particularly in the US.

The device, developed in Australia, provides detailed lung function insights from standard CT scans without additional nuclear medicine tests.

The funding will support R&D, clinical validation, and broader market access, strengthening both 4DMedical’s international growth and Australia’s local medical technology sector.

“Continued investment in advanced, locally developed imaging medical devices positions Australia to strengthen its diagnostic capabilities and expand its expertise, not only domestically but also globally,” Hasan said. “Over time, this momentum is expected to enhance the country’s role within the Asia-Pacific diagnostic imaging landscape.”